News

  • 29th July, 2021 - Press notes

    Mechanism that triggers brain neurone response revealed

    Mechanism that triggers brain neurone response revealed Researchers at the Hospital del Mar Medical Research Institute have shown for the first time how small areas of proteins on the surface of neurones control cell response by binding to neurotransmitters. Evolution has led to the existence of proteins with variations in these areas, capable of causing different cellular responses. This makes it possible to precisely regulate the neurone's response to the same neurotransmitter. It paves the way for the development of specific molecules that block areas linked to certain mental illnesses, such as schizophrenia, or to addictive behaviour. It is the first time it has been possible to see how neurotransmitters and proteins interact at the atomic level to trigger neuronal responses. The study has been published in the journal Chemical Science.

    more information

  • 21th July, 2021 - Press notes

    Having higher levels of omega-3 acids in the blood increases life expectancy by almost five years

    Having higher levels of omega-3 acids in the blood increases life expectancy by almost five years A 1% increase in this substance in the blood is associated with a change in mortality risk similar to that of quitting smoking. Conversely, being a smoker cancels out the positive effect of eating oily fish, the main source of omega-3 acids. The study, published in The American Journal of Clinical Nutrition, analysed data from more than 2,000 people participating in a population-based follow-up programme in the United States. Their progress has been studied over an eleven-year period. The researchers will try to validate the data using a European population.

    more information

  • 15th July 2021 - Press notes

    The Anti-Doping Laboratory of Catalonia collaborates with the Tokyo Olympic Laboratory

    The Anti-Doping Laboratory of Catalonia collaborates with the Tokyo Olympic Laboratory Two professionals from the Laboratory will travel to the Japanese capital to support the anti-doping work that will take place during the Olympic Games, which begin on July 23.

    more information

  • 13th July 2021 - Press notes

    A new approach to metastatic melanoma discovered

    A new approach to metastatic melanoma discovered Combining chemotherapy with a BRAF oncogene inhibitor proves effective at treating this disease. The study, published in the journal Oncogene, was led by researchers from the Hospital del Mar Medical Research Institute, Hospital del Mar and CIBERONC. This alternative paves the way towards a new approach for patients affected by this type of tumour, which has no cure in the most advanced stages or cases of relapse.

    more information

  • July 8th 2021 - Press notes

    Record funding for the Hospital del Mar Medical Research Institute from the Healthcare Research Projects at the Carlos III Institute of Health

    Record funding for the Hospital del Mar Medical Research Institute from the Healthcare Research Projects at the Carlos III Institute of Health The IMIM has obtained nearly 3.4 million euros in financing from this fund, 12% more than in the 2019 call for proposals, the most recent prior to the pandemic. 60% of the proposals submitted were approved, a record number in the history of the institution.

    more information

  • 22nd June, 2021 - Press notes

    More than 6% of Europeans suffer from depression

    More than 6% of Europeans suffer from depression A study in 27 European countries led by researchers from King's College London and the Hospital del Mar Medical Research Institute puts the prevalence of depression at 6.4% of the population. The work, published in The Lancet Public Health, analysed data from the European Health Interview Survey, which includes responses from more than 250,000 people. The incidence is higher in women at 7.7 per cent, while in men it is 4.9 per cent. Strong differences are seen between countries, with higher rates in more economically developed states.

    more information

  • June 17th, 2021 - Press notes

    Research finds that COVID-19 vaccines pre-prepared in syringes for their administration can be safely transported

    Research finds that COVID-19 vaccines pre-prepared in syringes for their administration can be safely transported Researchers from the Hospital del Mar and Pompeu Fabra University have confirmed that messenger RNA vaccines pre-prepared in syringes for their administration can be transported by road for up to three hours. This may be of great relevance in mass vaccination strategies, especially in rural and less developed areas, as the doses can be prepared in an official healthcare centre and then transported to remote vaccination sites or areas with an underdeveloped healthcare infrastructure. The researchers have conducted stress tests on syringes pre-prepared for administering the Pfizer BioNTech and Moderna vaccines, and have found that the vector these vaccines use, the messenger RNA, maintains its integrity despite being subjected to movement. The findings have been published in the medical journal Clinical Microbiology and Infection.

    more information

  • 9 June 2021 - Press notes

    Brain Alterations Detected in Obese Children

    Brain Alterations Detected in Obese Children The alterations link obesity to a brain condition similar to obsessive-compulsive disorder, which affects the same areas of the brain. Researchers analysed images of the brains of 230 children obtained by functional magnetic resonance imaging. This was the first study of these features in children. Published in the journal Cerebral Cortex, the study was carried out jointly by Hospital del Mar and the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation. The researchers believe the findings underscore the need for early intervention in child obesity, in order to prevent the alterations from becoming fixed in children's developing brains.

    more information

  • May 13th 2021 - Press notes

    Hospital del Mar leads clinical trial of a new tool for detecting the sentinel lymph node in prostate cancer

    Hospital del Mar leads clinical trial of a new tool for detecting the sentinel lymph node in prostate cancer The Urology and Nuclear Medicine and Radiology services at the centre are collaborating with the British company Lightpoint Medical to develop new equipment that will improve the detection of the sentinel lymph node in prostate cancer patients. Hospital del Mar is coordinating the international clinical trial to validate its usefulness. Hospitals from Germany, France, the United Kingdom, the Netherlands and Belgium are participating. The centre is a Spanish leader in the use of the prostate sentinel node technique. This involves injecting the tumour with a marker that drains through the lymph ducts and allows the first tumour drainage node to be detected.  Thanks to this technique, the treatment can be personalised and it is possible to identify more precisely whether the nodes are affected.

    more information

  • April 29th, 2021 - Press notes

    The future of immunotherapy at the Optimizing Immunotherapy Congress

    The future of immunotherapy at the Optimizing Immunotherapy Congress The benchmark meeting in the field of immunotherapy cancer treatment was held once again, on April 9, in a hybrid format. This year, the presentations focused on the research and development of this type of treatment for various types of tumours, as well as molecular diagnostics.

    more information

Social commitment

  • Social commitment
Collaborating entity

© 2006 - 2024 Parc de Salut Mar · Legal notice and Privacy Police | Cookie Policy | Accessibility